Maheswari Senthil

Has grant

Professor of Surgery

University of California, Irvine

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Maheswari Senthil is a Professor of Surgery at the University of California-Irvine, USA. Her research focuses on innovative treatments for gastric cancer, including chemotherapy approaches and the role of cytoreductive surgery. She has contributed significantly to the understanding of ovarian metastasis in gastric adenocarcinoma and the use of circulating tumor DNA as a biomarker in gastrointestinal cancers.

Recent Grants

Grant: Close

Exosomal biomarkers in peritoneal carcinomatosis

Open Date: 2016-03-01

Close Date: 2019-12-01

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (1)

Farshid Dayyani

University of California, Irvine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maheswari Senthil

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Ovarian Metastasis in Gastric Adenocarcinoma: Oophorectomy as Part of a Bigger Picture

Iterative Intraperitoneal Chemotherapy in Gastric Cancer Peritoneal Carcinomatosis

Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease

Cytoreduction and Heated Intraperitoneal Chemotherapy in Gastric Peritoneal Carcinomatosis: Selection is Key

Role of Iterative Normothermic Intraperitoneal Paclitaxel Combined with Systemic Chemotherapy in the Management of Gastric Peritoneal Carcinomatosis

Exosomes as a Source of Biomarkers for Gastrointestinal Cancers

Routine Omentectomy During Cytoreductive Surgery for Peritoneal Surface Malignancies

ASO Author Reflections: Challenges of Circulating Tumor DNA in the Management of Gastrointestinal Peritoneal Carcinomatosis

Adoption of cytoreductive surgery in the management of peritoneal malignancies—Global trends

Spontaneous Fluctuations of Tumor-Informed Circulating Tumor DNA at Low Levels

Cancer Screening Programs in Low- and Middle-Income Countries: Strategies for Success

Quality-of-Life Assessment in Patients Receiving Palliative Chemotherapy: Call for Action

ASO Author Reflections: Real-World Incidence of Peritoneal Carcinomatosis After Colon Cancer Resection and Why It Matters

Collaborators (1)

Farshid Dayyani

Make your next move.